Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)

NCT01102231 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Stage III Non-small Cell Lung Cancer

Interventions

DRUG: Chemotherapy
DRUG: ERBITUX
RADIATION: Radiotherapy

Sponsor

Intergroupe Francophone de Cancerologie Thoracique